Status:
COMPLETED
Pilot Study of Stellate Ganglion Injection to Provide Relief From Hot Flushes
Lead Sponsor:
Northwestern University
Conditions:
Hot Flashes
Menopause
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
This study is being done to determine whether stellate ganglion injection with local anesthetic (the study procedure) can reduce the number and severity of hot flashes in women who have hot flashes. ...
Eligibility Criteria
Inclusion
- Women surgically or naturally menopausal,
- Experiencing moderate to severe hot flushes, AND
- Elect to undergo stellate ganglion block procedure.
Exclusion
- Subjects who are currently sick,
- Subjects have acute infections or cardiac compromise,
- Subjects who have local infections of the anterior neck region, severe
- Subjects who have pulmonary disease,
- Subjects who are anticoagulated,
- Subjects who are on hormone therapy,
- Subjects who have a blood clotting disorder,
- Subjects who have an American Society of Anesthesiologists (ASA) physical status score of 3 or higher (severe systemic disease, not incapacitating),
- Subjects who have allergic reactions to local anesthetics and/or contrast dyes,
- Subjects who have past or present diagnosis of psychosis,
- Subjects who have current diagnosis of depression, OR
- Subjects who have current substance or alcohol abuse.
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00992914
Start Date
February 1 2009
End Date
December 1 2018
Last Update
May 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611